TNF and neoplasm: Notably, in the DMBA + skimmianine treatment group, the tumor burden appeared reduced in approximately 49% of the animals, as evidenced by partial preservation of the mammary gland architecture, fewer malignant clusters, and attenuated PCNA and TNF-α immunoreactivity (p = 0.191) (Figure 1D).